Total Valuation
Novo Nordisk has a market cap or net worth of kr1.33T. The enterprise value is kr1.49M.
Market Capkr1.33T
Enterprise Valuekr1.49M
Share Statistics
Novo Nordisk has 3,390,128,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,390,128,000
Owned by Insiders0.01%
Owned by Institutions<0.01%
Financial Efficiency
Novo Nordisk’s return on equity (ROE) is 0.53 and return on invested capital (ROIC) is 29.53%.
Return on Equity (ROE)0.53
Return on Assets (ROA)0.19
Return on Invested Capital (ROIC)29.53%
Return on Capital Employed (ROCE)0.39
Revenue Per Employee4.63M
Profits Per Employee1.54M
Employee Count66,700
Asset Turnover0.57
Inventory Turnover1.18
Valuation Ratios
The current PE Ratio of Novo Nordisk is 11.3. Novo Nordisk’s PEG ratio is ―.
PE Ratio11.3
PS Ratio0.00
PB Ratio0.00
Price to Fair Value7.45
Price to FCF0.00
Price to Operating Cash Flow9.86
PEG Ratio―
Income Statement
In the last 12 months, Novo Nordisk had revenue of 309.06B and earned 102.43B in profits. Earnings per share was 23.06.
Revenue309.06B
Gross Profit250.28B
Operating Income127.66B
Pretax Income130.54B
Net Income102.43B
EBITDA149.44B
Earnings Per Share (EPS)23.06
Cash Flow
In the last 12 months, operating cash flow was 133.01B and capital expenditures -84.09B, giving a free cash flow of 48.92B billion.
Operating Cash Flow133.01B
Free Cash Flow48.92B
Free Cash Flow per Share14.43
Dividends & Yields
Novo Nordisk pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.72
52-Week Price Change-10.80%
50-Day Moving Average307.47
200-Day Moving Average290.21
Relative Strength Index (RSI)46.34
Average Volume (3m)1.26M
Important Dates
Novo Nordisk upcoming earnings date is Nov 4, 2026, Before Open (Confirmed).
Last Earnings DateAug 4, 2026
Next Earnings DateNov 4, 2026
Ex-Dividend Date―
Financial Position
Novo Nordisk as a current ratio of 0.80, with Debt / Equity ratio of 63.33%
Current Ratio0.80
Quick Ratio0.57
Debt to Market Cap0.09
Net Debt to EBITDA0.70
Interest Coverage Ratio18.83
Taxes
In the past 12 months, Novo Nordisk has paid 28.11B in taxes.
Income Tax28.11B
Effective Tax Rate0.22
Enterprise Valuation
Novo Nordisk EV to EBITDA ratio is 10.37, with an EV/FCF ratio of 53.45.
EV to Sales5.01
EV to EBITDA10.37
EV to Free Cash Flow53.45
EV to Operating Cash Flow13.01
Balance Sheet
Novo Nordisk has kr44.98B in cash and marketable securities with kr118.72B in debt, giving a net cash position of -kr95.14B billion.
Cash & Marketable Securitieskr44.98B
Total Debtkr118.72B
Net Cash-kr95.14B
Net Cash Per Share-kr28.07
Tangible Book Value Per Sharekr14.40
Margins
Gross margin is 80.65%, with operating margin of 41.30%, and net profit margin of 33.14%.
Gross Margin80.65%
Operating Margin41.30%
Pretax Margin42.24%
Net Profit Margin33.14%
EBITDA Margin48.35%
EBIT Margin43.60%
Analyst Forecast
The average price target for Novo Nordisk is kr296.69, which is 11.43% higher than the current price. The consensus rating is Hold
Price Targetkr296.69
Price Target Upside-7.46% Downside
Analyst ConsensusHold
Analyst Count14
Revenue Growth Forecast5.61%
EPS Growth Forecast5.07%